ME Therapeutics Holding (XCNQ:METX) FCF Margin % : 0.00% (As of Feb. 2024)

View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ME Therapeutics Holding's Free Cash Flow for the three months ended in Feb. 2024 was C$-0.10 Mil. ME Therapeutics Holding's Revenue for the three months ended in Feb. 2024 was C$0.00 Mil. Therefore, ME Therapeutics Holding's FCF Margin % for the quarter that ended in Feb. 2024 was 0.00%.

As of today, ME Therapeutics Holding's current FCF Yield % is -0.60%.

The historical rank and industry rank for ME Therapeutics Holding's FCF Margin % or its related term are showing as below:

XCNQ:METX's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -139.2
* Ranked among companies with meaningful FCF Margin % only.

ME Therapeutics Holding FCF Margin % Historical Data

The historical data trend for ME Therapeutics Holding's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding FCF Margin % Chart

ME Therapeutics Holding Annual Data

Trend

Aug22

Aug23

FCF Margin %

ME Therapeutics Holding Quarterly Data
	Aug22	Dec22	May23	Aug23	Nov23	Feb24
FCF Margin %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of ME Therapeutics Holding's FCF Margin %

For the Biotechnology subindustry, ME Therapeutics Holding's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ME Therapeutics Holding's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's FCF Margin % distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's FCF Margin % falls into.

ME Therapeutics Holding FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ME Therapeutics Holding's FCF Margin for the fiscal year that ended in Aug. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Aug. 2023 )	/	Revenue (A: Aug. 2023 )
	=	-0.303	/	0
	=	%

ME Therapeutics Holding's FCF Margin for the quarter that ended in Feb. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Feb. 2024 )	/	Revenue (Q: Feb. 2024 )
	=	-0.099	/	0
	=	%

ME Therapeutics Holding FCF Margin % Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

Q9T:Germany

Address

177 Robson Street, Vancouver, BC, CAN, V6B 0N3

Website

https://www.metherapeutics.com

ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines